L Dubuisson

865 total citations
30 papers, 682 citations indexed

About

L Dubuisson is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, L Dubuisson has authored 30 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 9 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in L Dubuisson's work include Liver Disease Diagnosis and Treatment (8 papers), Liver Disease and Transplantation (8 papers) and Liver physiology and pathology (7 papers). L Dubuisson is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Liver Disease and Transplantation (8 papers) and Liver physiology and pathology (7 papers). L Dubuisson collaborates with scholars based in France, Belize and Germany. L Dubuisson's co-authors include Paulette Bioulac‐Sage, Jean Rosenbaum, Alexis Desmoulière, Charles Balabaud, Hugues Bégueret, José Manuel Tunon-de-Lara, Patrick Berger, Roger Marthan, J.‐M. Vernejoux and Sébastien Lepreux and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

L Dubuisson

30 papers receiving 666 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Dubuisson France 12 267 192 142 138 129 30 682
Ilaria Petrai Italy 10 387 1.4× 452 2.4× 122 0.9× 155 1.1× 74 0.6× 14 784
Monica Curto Italy 16 140 0.5× 129 0.7× 145 1.0× 323 2.3× 51 0.4× 22 829
Nobuko Serizawa Japan 7 182 0.7× 205 1.1× 73 0.5× 145 1.1× 61 0.5× 18 535
Lidia Tihaa Germany 12 217 0.8× 224 1.2× 99 0.7× 322 2.3× 41 0.3× 14 695
Núria Tarrats United Kingdom 12 158 0.6× 224 1.2× 99 0.7× 337 2.4× 222 1.7× 13 763
Takuya Komura Japan 14 197 0.7× 230 1.2× 193 1.4× 158 1.1× 52 0.4× 41 738
Tamara Severi Belgium 9 287 1.1× 238 1.2× 96 0.7× 198 1.4× 32 0.2× 10 604
Detlef Schuppan Germany 7 508 1.9× 316 1.6× 210 1.5× 214 1.6× 33 0.3× 8 771
Maja Katrin Tietze Germany 8 84 0.3× 81 0.4× 138 1.0× 275 2.0× 204 1.6× 9 622
Elisabetta Mormone Italy 11 161 0.6× 212 1.1× 74 0.5× 317 2.3× 68 0.5× 18 727

Countries citing papers authored by L Dubuisson

Since Specialization
Citations

This map shows the geographic impact of L Dubuisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Dubuisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Dubuisson more than expected).

Fields of papers citing papers by L Dubuisson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Dubuisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Dubuisson. The network helps show where L Dubuisson may publish in the future.

Co-authorship network of co-authors of L Dubuisson

This figure shows the co-authorship network connecting the top 25 collaborators of L Dubuisson. A scholar is included among the top collaborators of L Dubuisson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Dubuisson. L Dubuisson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bégueret, Hugues, Patrick Berger, J.‐M. Vernejoux, et al.. (2006). Inflammation of bronchial smooth muscle in allergic asthma. Thorax. 62(1). 8–15. 105 indexed citations
2.
Dubuisson, L, Alexis Desmoulière, Boris Decourt, et al.. (2002). Inhibition of rat liver fibrogenesis through noradrenergic antagonism. Hepatology. 35(2). 325–331. 66 indexed citations
3.
Lamireau, Thierry, L Dubuisson, Sébastien Lepreux, et al.. (2002). Abnormal Hepatic Expression of Fibrillin-1 in Children With Cholestasis. The American Journal of Surgical Pathology. 26(5). 637–646. 11 indexed citations
4.
Dubuisson, L, Sébastien Lepreux, Paulette Bioulac‐Sage, et al.. (2001). Expression and cellular localization of fibrillin-1 in normal and pathological human liver. Journal of Hepatology. 34(4). 514–522. 53 indexed citations
5.
Krisa, Stéphanie, et al.. (2000). Deactivation of cultured human liver myofibroblasts by Trans -resveratrol, a grapevine-derived polyphenol. Hepatology. 31(4). 922–931. 86 indexed citations
6.
Dubuisson, L, Arnaud Monvoisin, Boye Schnack Nielsen, et al.. (2000). Expression and cellular localization of the urokinase-type plasminogen activator and its receptor in human hepatocellular carcinoma. The Journal of Pathology. 190(2). 190–195. 48 indexed citations
7.
Monvoisin, Arnaud, Véronique Neaud, L Dubuisson, et al.. (1999). Direct evidence that hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells is mediated by urokinase. Journal of Hepatology. 30(3). 511–518. 57 indexed citations
8.
Faouzi, Saadia, Sébastien Lepreux, L Dubuisson, et al.. (1999). Activation of cultured rat hepatic stellate cells by tumoral hepatocytes.. PubMed. 79(4). 485–93. 58 indexed citations
9.
Ennamany, R., A Bingen, E.E. Creppy, et al.. (1998). Aspirin® and heparin prevent hepatic blood stasis and thrombosis induced by the toxic glycoprotein Bolesatine in mice. Human & Experimental Toxicology. 17(11). 620–624. 5 indexed citations
10.
Weill, François‐Xavier, Sylvie Blazejewski, Jean‐Frédéric Blanc, et al.. (1997). Characterization of a new human liver myofibroblast cell line: transcriptional regulation of plasminogen activator inhibitor type I by transforming growth factor beta 1.. PubMed. 77(1). 63–70. 20 indexed citations
12.
Dubuisson, L, et al.. (1995). Ultrastructure of human Kupffer cells maintained in culture.. PubMed. 27(2). 161–70. 4 indexed citations
13.
Bioulac‐Sage, Paulette, et al.. (1992). Nodular Regenerative Hyperplasia in the Rat Induced by A Selenium–Enriched Diet: Study of A Model. Hepatology. 16(2). 418–425. 17 indexed citations
14.
Dubuisson, L, Paulette Bioulac‐Sage, L. Boussarie, et al.. (1987). Removal of cellular debris formed in the Disse space in patients with cholestasis. PubMed. 410(6). 501–507. 6 indexed citations
15.
Dubuisson, L, et al.. (1985). Hyperplastic foci in the atrophic liver of rats after portacaval anastomosis. Liver International. 5(1). 21–28. 7 indexed citations
16.
Dubuisson, L, et al.. (1985). The sinusoidal barrier in rats with portacaval anastomosis: A morphometric study. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 407(3). 347–357. 4 indexed citations
17.
Dubuisson, L, et al.. (1984). Hypertrophy of the rat Golgi complex during enhancement of cholesterol and bile acids synthesis.. PubMed. 16(4). 721–6. 1 indexed citations
18.
Dubuisson, L, et al.. (1984). Ultrastructural characteristics of hyperplastic alterations in the liver of congenital portacaval-shunt rats.. PubMed. 65(5). 585–96. 8 indexed citations
19.
Bioulac‐Sage, Paulette, et al.. (1984). [Morphometric analysis of normal human liver by electron microscopy].. PubMed. 8(11). 856–60. 3 indexed citations
20.
Bioulac, P, L Dubuisson, Jean Saric, & Charles Balabaud. (1979). [Ultrastructural study of the different zones of the rat liver acinus after portacaval anastomosis].. PubMed. 173(1). 60–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026